Timmy Davis

Researcher, Conservative Drug Policy Reform Group

As the Psilocybin Rescheduling Project manager Timmy Davis’ primary duty is collating and presenting the evidence for a change in psilocybin’s classification as a Schedule 1 substance under the Misuse of Drugs Regulation 2001. Timmy uses the case of psilocybin as indicative of a wider need for reassessment of the status of many other Schedule 1 substances, such as MDMA. Timmy also contributes to research on routes of access to medical cannabis and is training as a psychoanalytic psychotherapist with the SITE for Contemporary Psychoanalysis.